Phillip J Finley1, Cory E DeClue2, Scott A Sell3, Joseph M DeBartolo2, Laurie P Shornick4. 1. Department of Biology, Saint Louis University, Saint Louis, Missouri.; Division of Trauma and Burn Research, Mercy Hospital, Springfield, Missouri. 2. Department of Biology, Saint Louis University , Saint Louis, Missouri. 3. Department of Biomedical Engineering, Saint Louis University , Saint Louis, Missouri. 4. Department of Biology, Saint Louis University, Saint Louis, Missouri.; Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, Missouri.
Abstract
Objective: Impaired wound healing in diabetic (DB) patients is a significant health problem; however, the roles that cytokines and innate immune cells contribute to this impaired healing are not completely understood. Approach: A mouse model was used to compare the innate immune response during DB and normal wound healing. Two 5-mm full-thickness wounds were created on the dorsal skin of BKS.Cg-m+/+Leprdb/J (DB) and C57BL/6 (wild-type) mice. Innate immune cell markers and cytokine mRNA levels were measured in wound biopsies during the first week of healing. Results: Innate immune cell influx (typified by the Gr-1 neutrophil marker and the Ym1 macrophage marker) was delayed in the DB wounds. Expression of the M2 macrophage-related genes, Ym1 and arginase 1, was significantly reduced in the DB wounds. PCR array analysis demonstrated altered cytokine expression in DB wounds. Most prominently, both interleukin (IL)-17 and IL-20 mRNA levels were significantly increased in the DB wounds. Innovation: This is the first study to identify increased levels of IL-17 and IL-20 in DB wounds. These cytokines are also elevated in the inflammatory skin disorder, psoriasis; thus, they may be potential therapeutic targets to aid in DB wound healing. Conclusion: The entire cytokine profile of DB wounds over the course of healing is not completely understood. This study suggests that the IL-17 and IL-20 families of cytokines should be further analyzed in the context of DB wound healing.
Objective: Impaired wound healing in diabetic (DB) patients is a significant health problem; however, the roles that cytokines and innate immune cells contribute to this impaired healing are not completely understood. Approach: A mouse model was used to compare the innate immune response during DB and normal wound healing. Two 5-mm full-thickness wounds were created on the dorsal skin of BKS.Cg-m+/+Leprdb/J (DB) and C57BL/6 (wild-type) mice. Innate immune cell markers and cytokine mRNA levels were measured in wound biopsies during the first week of healing. Results: Innate immune cell influx (typified by the Gr-1 neutrophil marker and the Ym1 macrophage marker) was delayed in the DB wounds. Expression of the M2 macrophage-related genes, Ym1 and arginase 1, was significantly reduced in the DB wounds. PCR array analysis demonstrated altered cytokine expression in DB wounds. Most prominently, both interleukin (IL)-17 and IL-20 mRNA levels were significantly increased in the DB wounds. Innovation: This is the first study to identify increased levels of IL-17 and IL-20 in DB wounds. These cytokines are also elevated in the inflammatory skin disorder, psoriasis; thus, they may be potential therapeutic targets to aid in DB wound healing. Conclusion: The entire cytokine profile of DB wounds over the course of healing is not completely understood. This study suggests that the IL-17 and IL-20 families of cytokines should be further analyzed in the context of DB wound healing.
Authors: Savita Khanna; Sabyasachi Biswas; Yingli Shang; Eric Collard; Ali Azad; Courtney Kauh; Vineet Bhasker; Gayle M Gordillo; Chandan K Sen; Sashwati Roy Journal: PLoS One Date: 2010-03-04 Impact factor: 3.240
Authors: Itamar Goren; Elke Müller; Dana Schiefelbein; Urs Christen; Josef Pfeilschifter; Heiko Mühl; Stefan Frank Journal: J Invest Dermatol Date: 2007-04-26 Impact factor: 8.551
Authors: Richard G Langley; Boni E Elewski; Mark Lebwohl; Kristian Reich; Christopher E M Griffiths; Kim Papp; Lluís Puig; Hidemi Nakagawa; Lynda Spelman; Bárður Sigurgeirsson; Enrique Rivas; Tsen-Fang Tsai; Norman Wasel; Stephen Tyring; Thomas Salko; Isabelle Hampele; Marianne Notter; Alexander Karpov; Silvia Helou; Charis Papavassilis Journal: N Engl J Med Date: 2014-07-09 Impact factor: 91.245
Authors: Machteld M Tiemessen; Ann L Jagger; Hayley G Evans; Martijn J C van Herwijnen; Susan John; Leonie S Taams Journal: Proc Natl Acad Sci U S A Date: 2007-11-27 Impact factor: 11.205
Authors: Kang I Ko; Abby L Syverson; Richard M Kralik; Jerry Choi; Brett P DerGarabedian; Chider Chen; Dana T Graves Journal: Diabetes Date: 2019-08-22 Impact factor: 9.461